Black men with advanced prostate cancer have a greater chance of survival after immunotherapy treatment, at least in part, because of ancestral gene variants in immune responses. That connection is ...
Immunotherapy for stage 4 prostate cancer is revolutionizing the way advanced disease is being treated, offering hope for patients worldwide. Unlike conventional treatment methods such as surgery and ...
Delivery of a new nanoparticle-based immunotherapy to perivascular tumour-associated macrophages (TAMs) in androgen deprivation therapy (ADT)-treated prostate tumours may increase antitumour immunity ...
New research has shown that immunotherapy can be effective in treating prostate cancer in men who are selected based on the genetic characteristics of their tumors. In a recent study conducted at ...
1don MSN
Janux Therapeutics Stock Craters After ‘Positive’ Cancer Drug Trial Data. Why It’s Down 41%.
Janux posts what it called ‘positive trial data’ for its novel treatment in patients with late-stage prostate cancer.
New research has shown that immunotherapy can be effective in treating prostate cancer in men who are selected based on the genetic characteristics of their tumors. In a recent study, it was found ...
Researchers at the University of Arizona Health Sciences have uncovered a promising new approach for treating prostate cancer through a combination of immunotherapy and a targeted treatment strategy.
Immunotherapy is simply a term that describes utilizing your own body's immune system to fight cancer cells. It's often been called a prostate cancer vaccine. After discussion with their doctor, men ...
Adding a pre-ketone supplement — a component of a high-fat, low-carb ketogenic diet — to a type of cancer therapy in a laboratory setting was highly effective for treating prostate cancer, researchers ...
Black men with advanced prostate cancer have a greater chance of survival after immunotherapy treatment, at least in part, because of ancestral gene variants in immune responses. Black men with ...
FDA’s Office of Cellular, Tissue and Gene Therapies Advisory Committee recommended to the agency that there is substantial evidence of efficacy and safety of Provenge (sipuleucel-T), made by Dendreon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results